Related Experiment Video
Updated: Jan 20, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistance
Annette Rid1, Jasper Littmann2, Alena Buyx3
1Department of Bioethics, The Clinical Center, National Institutes of Health, Bethesda, Maryland, United States.
Abstract:
Existing ethical frameworks for public health provide insufficient guidance on how to evaluate the risks of public health programs that compromise the best clinical interests of present patients for the benefit of others. Given the relevant similarity of such programs to clinical research, we suggest that insights from the long-standing debate about acceptable risk in clinical research can helpfully inform and guide the evaluation of risks posed by public health programs that compromise patients' best clinical interests. We discuss how lessons learned regarding the ethics of risk in one context can be fruitfully transferred to the other, using the example of a so-called 'rational antibiotic use' guideline that limits antimicrobial prescribing in order to curb antimicrobial resistance.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Rational Emotive Behavior Therapy
Antimicrobial Effectiveness
Relative Risk
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

